BioBehavioral Diagnostics
BioBehavioral Diagnostics (acquired by Pearson) was formed in 2004 to develop instrumentation for objective assessment and management of Attention Deficit Hyperactivity Disorder (ADHD), including medication response. The technology utilizes a set of proprietary bio-surrogate measurements to enable the accurate assessment and management of ADHD.
